David Piacquad
SVP, Business Development, Amgen.
Companies
- Neumora Therapeutics, Inc.Board member Sep 14, 2023 to now1
- AmgenSVP, Business Development Mar 18, 2014 to May 4, 20212
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Neumora Therapeutics, Inc. NMRA20,100 shares3$8.6K at $0.43Jun 13, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 13, 2024Granted 20,100 shares of Neumora Therapeutics, Inc.3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARAmgen, SVP, Business Development
- 3